
Episode 91: Nuances of the Newest Leukemia Classification
- July 19, 2022
- Chadi Nabhan

Episode 91: Nuances of the Newest Leukemia Classification
Returning guests Sanam Loghavi, MD, hematopathologist and molecular pathologist, University of Texas MD Anderson Center, and Aaron Goodman, MD, hematologist, University of California San Diego, break down the latest classification system updates in leukemia. They begin by explaining what triggers a new classification and why it is needed, how soon clinicians should adopt it, and the relationship as well as differences between the ICC and WHO classification systems. Then, the experts go into the details of the changes that have been made to AML and MDS diagnoses and how these are likely to impact clinical trials, among other important points.
Related Resources
N/A
Other Episodes You May Enjoy...


Episode 206: Fireside Chat With Joe Mikhael, the CMO of the IMF
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding

Episode 205: Multi-Cancer Early Detection (MCED): Now and Later
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary